Executive Summary
Across 50 filings in the 'Global High Priority Market Events' stream, dominant themes include intense SPAC activity (mergers, IPOs, terminations), major M&A completions/announcements (Cintas-UniFirst $5.5B, Sonida-CNHL $1.8B), mixed financial results with outliers like AeroVironment's 143% YoY revenue surge and C3.ai's 46% YoY plunge, positive insolvency resolutions in India, and minor regulatory fines. Period-over-period trends show revenue growth averaging +20% YoY in high-performers (e.g., Oracle +22%, ICL operating income +47%) but sharp declines in others (-4-46% YoY), with net losses widening in 6/10 detailed reports due to impairments/expenses; capital allocation favors dividends (ICL 3.1% yield, Smurfit +5%) over buybacks. Critical developments like SPAC approvals (TLGY 97% vote) and deal accretions signal bullish consolidation, while Nasdaq delisting risks (GameSquare) and guidance-absent distress (Fenoplast 95% dilution) pose threats. Portfolio-level patterns highlight SPAC resilience amid redemptions (avg 6-100%), Indian regulatory resolutions boosting stability, and tech/hardware growth vs. software weakness, implying opportunities in M&A plays and risks in high-debt growers like Oracle ($134B debt).
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from March 10, 2026.
Investment Signals(12)
- ICL Group Ltd↓(BULLISH)▲
Adjusted net income +48% YoY to $715M, operating income +47% YoY to $1,141M, $232M dividends (3.1% yield), strong cash flow $1,056M
- Oracle Corp↓(BULLISH)▲
Q3 revenue +22% YoY to $17.2B (Cloud +44% to $8.9B), 9-mo net income +42% to $12.8B, dividends up to $1.50/share, operating cash +18%
- AeroVironment Inc↓(BULLISH)▲
Q3 revenue +143% YoY to $408M (9-mo +145% to $1.3B via acquisitions), Precision Strike +87%, assets to $5.45B
- Cintas Corp↓(BULLISH)▲
Q3 prelim revenue +8.9% YoY to $2.84B (organic +8.2%), UniFirst acquisition at 8x EBITDA with $375M synergies, EPS accretion yr2
- Sonida Senior Living↓(BULLISH)▲
$1.8B merger complete, 62% Normalized FFO accretion, 153 communities/14.7k units, Sonida shareholders own 50%
- TLGY Acquisition Corp↓(BULLISH)▲
97% shareholder approval for StablecoinX merger (5.8M yes votes), low redemptions 6.7%, S-4 effective Feb 2026
- Kamada Ltd↓(BULLISH)▲
FY2026 guidance revenues $200-205M (+13% YoY mid), adj EBITDA $50-53M (+23%), plasma ramps $8-10M/site annually
- Smurfit Westrock↓(BULLISH)▲
2025 sales $31.2B, Adj EBITDA $4.9B (15.8% margin), exceeded $400M synergies, dividend +5% to $0.4523/share
- Johnson & Johnson↓(BULLISH)▲
Exceptional 2025 performance in Oncology/Immunology, Orthopaedics spin-off, >2.8B Vermox doses, GHG -26%
- Ryder System Inc↓(BULLISH)▲
2025 EPS $11.99 (+8.4% YoY), revenue $12.7B, comparable EBITDA +3.6% to $2.9B, TSR +146% vs peers
- GameSquare Holdings↓(NEUTRAL-BULLISH)▲
Nasdaq extension to Sep 7 2026 for $1 bid compliance, meets other requirements, reverse split planned
- Adani Ports↓(BULLISH)▲
CareEdge BBB+/Stable rating upgrade intimation, positive credit outlook
Risk Flags(10)
- C3.ai↓[HIGH RISK]▼
Q3 revenue -46% YoY to $53.3M (sub -44%, services -61%), gross profit -84% to $9.2M, net loss -66% to $133.4M
- Yotta Acquisition Corp↓[HIGH RISK]▼
Terminated DRIVEiT merger (Aug 2024 agreement), no new deal, SPAC clock ticking
- Fenoplast Limited[HIGH RISK]▼
NCLT-approved 95% public share cancellation (19/20 shares), 100% promoter extinction, record date Mar 23 2026
- GameSquare Holdings↓[HIGH RISK]▼
Nasdaq 2nd deficiency notice, failed initial 180-day $1 bid period, delisting risk if no compliance by Sep 7 2026
- Sagimet Biosciences↓[HIGH RISK]▼
Net loss +12% YoY to $51M, cash burn $45.7M ops (vs $42.4M), financing inflows -99% to $0.3M
- Campbell's Co↓[MEDIUM RISK]▼
Q net sales -4.5% YoY to $2,564M, net earnings -16.2% to $145M; 6-mo sales -4%, earnings -13.3%
- InterGlobe Aviation↓[MEDIUM RISK]▼
GIC/GOS/MAS sold 485k shares (0.126%), stake down to 2.98% from 3.11%, ongoing sales since Dec 2024
- Athena Tech Acq II[HIGH RISK]▼
Trust assets -92% YoY to $298k, redemptions slashed shares 92%, liabilities $18M vs assets $1.4M
- ON Semiconductor↓[MEDIUM RISK]▼
Power Solutions Group President resigns Jun 30 2026, transition risk
- Kirloskar Industries / Regulatory↓[LOW RISK]▼
NSE fine ₹2,360 for Reg 31(1) delay, potential promoter freeze if unresolved
Opportunities(10)
- Cintas-UniFirst Merger↓(OPPORTUNITY)◆
$5.5B EV at 8x EBITDA, $375M synergies (4 yrs), H2 2026 close, enhances 1.5M customer base, net leverage 1.5x
- Sonida-CNHL Merger↓(OPPORTUNITY)◆
62% FFO accretion run-rate, $3.3B platform #8 US senior living, $930M debt financing
- Oracle Cloud Growth(OPPORTUNITY)◆
+44% YoY to $8.9B despite flat software, capex $39.2B signals AI bet, cash flow +18%
- AeroVironment Acquisitions(OPPORTUNITY)◆
+143% revenue via Space/Cyber adds, $845M deals funded by $2.6B equity/debt
- Kamada Guidance(OPPORTUNITY)◆
+13-23% rev/EBITDA growth FY26, biosimilars $15-20M (4-5 yrs), plasma sites H1 2026 FDA
- TLGY-StablecoinX Merger↓(OPPORTUNITY)◆
Near-100% approval, low 6.7% redemptions, post-merger catalysts
- ICL Dividends/Cash(OPPORTUNITY)◆
$1,056M op cash, 3.1% yield, +47% op income, Zin reserves to 2040
- Smurfit Westrock MTN(OPPORTUNITY)◆
2030 plan post-synergies beat, 23M ton capacity, dividend growth
- Advasa Holdings Direct Listing(OPPORTUNITY)◆
Nasdaq 'ADBT' pending, 485M shares resale, post 10:1 split
- Marsons IPO Listing(OPPORTUNITY)◆
NSE main board Mar 13 2026, 172M shares no lock-in
Sector Themes(6)
- SPAC Consolidation Surge◆
10/50 filings SPAC-related; 4 approvals/extensions (TLGY 97% vote, GameSquare +180 days), 1 termination (Yotta), avg redemptions 6-92%, IPOs $100-150M targeting $200M-1.5B EV; implies de-risking via mergers amid redemptions pressure
- M&A Accretion in Services/Healthcare◆
Cintas-UniFirst ($5.5B, 62% EPS/FFO acc), Sonida-CNHL ($1.8B, #8 senior living); synergies $375M, low leverage 1.5x; contrasts SPAC risks, favors pure-plays with customer scale
- Mixed Tech Revenue Extremes◆
Growth outliers (Oracle Cloud +44%, Aero +143%) vs declines (C3.ai -46%, Campbell -4.5%); 5/8 detailed show op cash flat/negative, capex spikes (Oracle $39B); AI/hardware winners, software laggards
- Indian Insolvency Resolutions Positive◆
4/50 (Godawari merger, Williamson withdrawal, Fenoplast dilution offset by resolution, Narayana corrigendum); 100% promoter hits but public dilution 95% in one; enhances group synergies/flexibility
- Dividend Resilience Amid Losses◆
ICL/Smurfit/Ryder/JNJ up 3-5% yields/payouts despite mixed earnings (ICL +47% income, Ryder +8% EPS); 6 cos prioritize returns vs buybacks, signals confidence in cash flows
- Regulatory Fines Minor but Widespread India◆
4 fines ₹2k-53k (Kirloskar, Gujarat, Cummins) for board/audit delays; waivers pending, low materiality (2-4/10) but watch compliance freezes
Watch List(8)
Monitor reverse split and $1 bid for 10-20 days by Sep 7 2026, delisting risk
HSR/regulatory approvals, shareholder 2/3 vote, H2 2026 close, termination fees $213-350M
- Fenoplast / Record Date👁
Mar 23 2026 for 95% dilution, post-NCLT insolvency impact on public shareholders
Redemption vote for Greenland merger, Cayman status vs potential retro IRS changes
- JNJ / AGM👁
Apr 23 2026 virtual, director elections, NEO pay vote, Orthopaedics spin details
May 1 2026 Dublin, director changes, 2030 MTN guidance updates
May 1 2026, EPS outlook post-freight downturn, indep chair proposal
H1 2026 San Antonio approval, biosimilar launches Israel 2026, rev guide $200-205M
Filing Analyses(50)
11-03-2026
On March 6, 2026, the Board of Directors of Power Solutions International, Inc. (PSIX) approved the Power Solutions International, Inc. 2026 Phantom Unit Plan, a cash-settled incentive program designed to incentivize eligible service providers through Phantom Units tied to the fair market value of the Company's common stock. Phantom Units vest in three equal annual installments subject to continuous service, with accelerated vesting upon death, disability, or certain change in control events, and settle in cash within 60 days of vesting. No specific grant amounts or participant details were disclosed in the filing.
- ·Phantom Units determined by dividing award dollar value by average FMV over 30 trading days prior to grant date.
- ·Settlement based on average FMV over 30 trading days preceding vesting date.
- ·Accelerated vesting on involuntary termination or good reason resignation within 24 months post-change in control if awards assumed.
- ·Plan administered by Board or committee with full discretionary authority; subject to clawback policies.
11-03-2026
Adani Ports and Special Economic Zone Limited has been assigned a Long-Term Foreign Currency Issuer Rating of ‘CareEdge BBB+/Stable’ by CareEdge Global. This intimation complies with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was disclosed on March 11, 2026. No comparative prior ratings or negative factors were mentioned.
- ·Reference No: APSEZL/SECT/2025-26/149
- ·Scrip Codes: 532921 (BSE), ADANIPORTS (NSE)
11-03-2026
The Hon'ble National Company Law Tribunal, Cuttack Bench sanctioned the Scheme of Amalgamation of Godawari Energy Limited (wholly-owned subsidiary, Transferor Company) with Godawari Power and Ispat Limited (Transferee Company) on March 10, 2026, with an Appointed Date of April 1, 2025. The scheme seeks to consolidate group structure, achieve business synergies, and enhance financial strength and flexibility, without issuing new shares to shareholders. The order is uploaded on the Tribunal's website, and the scheme becomes effective upon filing the certified copy with the Registrar of Companies.
- ·Previous updates via letters dated August 05, 2025; August 30, 2025; October 16, 2025; November 18, 2025.
- ·Tribunal dispensed with meetings of shareholders, debenture holders, and creditors due to consents and wholly-owned subsidiary status.
- ·Notices served to regulators including Regional Director (MCA), ROC Chhattisgarh, SEBI, BSE, NSE, and Income Tax authorities.
11-03-2026
BEST SPAC II Acquisition Corp., a blank check company incorporated in the British Virgin Islands and targeting consumer goods sector businesses with enterprise values between $200M and $1B, filed an S-1 registration statement for a $100M IPO of 10M units priced at $10 each, with each unit consisting of one Class A ordinary share and one right entitling the holder to 1/10 of a Class A share upon business combination. The offering includes a 45-day over-allotment option for 1.5M additional units and a simultaneous private placement of 382K units for $3.82M to the sponsor and others. The company has 18 months from IPO closing to complete an initial business combination or face full redemption of public shares.
- ·Public shareholders can redeem up to 15% of shares upon business combination.
- ·Founder shares purchased by sponsor at approx. $0.0079 per share; up to 500K subject to forfeiture based on over-allotment.
- ·Sponsor founder share transactions: 1,581,250 shares for $25K on Dec 13, 2024; 3,833,333 for $25K on Jan 20, 2026; subsequent adjustments and forfeitures.
- ·Business address: Sun’s Group Center, 29th Floor, 200 Gloucester Road, Wan Chai, Hong Kong.
11-03-2026
Hannah Joseph Hospital Limited has notified BSE Limited of the listing of its equity shares on the BSE SME platform, with scrip code 544687, symbol HANNAH, and ISIN INE0JVH01012. As a result, the company's CIN has been updated in MCA records from U74999TN2011PLC082860 to L74999TN2011PLC082860 to reflect the 'Listed' status. No financial metrics or performance data were disclosed in this administrative update.
- ·Filing Date: March 11, 2026
- ·Old CIN: U74999TN2011PLC082860
- ·New CIN: L74999TN2011PLC082860
- ·Registered Office: Lake View Road, R.S.No: 115/382 & 116/1A2, K.K.Nagar, Madurai - 625 020, Tamil Nadu, India
- ·Corporate Office: Madurai-Tuticorin Ring Road, Chinthamani, Madurai - 625 009, Tamil Nadu, India
11-03-2026
Williamson Magor & Company Limited disclosed the withdrawal of an insolvency application under Section 7 of the Insolvency and Bankruptcy Code, 2016, filed by Carnex Timbers Pvt Ltd before the NCLT, Kolkata Bench. The parties jointly submitted on March 10, 2026, that the matter was fully and finally settled, leading to the dismissal of the application as withdrawn. No financial impact or ongoing proceedings were mentioned.
- ·Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- ·NCLT, Kolkata Bench dismissed the application
- ·Copy of the NCLT order to be disclosed upon receipt
11-03-2026
ON Semiconductor Corporation (onsemi) announced on March 9, 2026, that Simon Keeton, Group President of the Power Solutions Group, will resign from all employment positions effective June 30, 2026, immediately stepping down from officer roles but remaining to ensure an orderly transition. Keeton joined onsemi in July 2007 and assumed his current role in February 2024. The filing was signed by Paul Dutton, Senior Vice President, Chief Legal Officer and Secretary.
- ·Agreement reached on March 9, 2026
- ·Filing submitted on March 11, 2026
11-03-2026
GameSquare Holdings, Inc. received a second Nasdaq notice on March 10, 2026, granting an additional 180 calendar days until September 7, 2026, to regain compliance with the $1.00 minimum bid price rule after failing the initial 180-day period ending March 9, 2026. The company meets other Nasdaq Capital Market listing requirements except bid price and plans a potential reverse stock split. However, failure to achieve $1.00 closing bid price for 10-20 consecutive business days risks delisting, with no assurance of compliance.
- ·Initial deficiency notice received September 10, 2025, for 30 consecutive business days below $1.00 bid price.
- ·Reverse stock split, if implemented, must be completed no later than 10 business days prior to September 7, 2026.
- ·Company eligible for extension based on meeting market value of publicly held shares and other initial listing requirements.
11-03-2026
ICL Group Ltd. reported strong operating cash flow of $1,056 million in 2025 and declared total dividends of $232 million, reflecting a 3.1% yield based on average share price. Reported operating income grew significantly YoY to $1,141 million in 2025 from $775 million prior year (+47%), and adjusted net income rose to $715 million (+48% YoY). However, adjusted operating income remained flat at $873 million between the first two years before increasing to $1,218 million, with notable adjustments including $131 million in impairments/write-offs and $54 million in security-related charges.
- ·Zin site life of mine: 2026 to 2040 based on 3 Mt reserves of low organic phosphate.
- ·Charges related to security situation in Israel: $54M (2023), $57M (2024), $14M (2025).
- ·Legal proceedings, dispute, and other settlement expenses: $80M (2023), $2M (2024), -$2M (2025).
11-03-2026
Yotta Acquisition Corporation terminated its Business Combination Agreement, dated August 20, 2024, with DRIVEiT Financial Auto Group, Inc. and other parties, effective March 4, 2026, by providing written notice pursuant to Article 10. No separate termination agreement was entered into, ending the previously disclosed merger plans. This development represents a setback for the SPAC's primary business combination objective.
- ·Securities registered: Units (YOTAU), Common Stock (YOTA), Warrants (YOTAW), Rights (YOTAR) on Nasdaq Stock Market LLC
- ·Company is an emerging growth company
11-03-2026
Ally Auto Assets LLC (Depositor) entered into a Trust Sale Agreement dated March 10, 2026, with Ally Auto Receivables Trust 2026-1 (Issuing Entity), conveying auto loan receivables previously purchased from Ally Bank in exchange for Notes and Certificates. The agreement includes representations and warranties on the receivables, repurchase obligations upon breach within specified timelines, and dispute resolution via ADR if repurchases are not fulfilled. No financial performance metrics or pool sizes are disclosed in the filing.
- ·Repurchase obligation triggered as of the last day of the second Monthly Period following breach discovery (or first at Depositor's election)
- ·Unfulfilled repurchase demands may lead to ADR referral within 180 days of Repurchase Request and within 30 days of unresolved notice
- ·ADR Proceedings (including Mediation) to occur in New York, NY, with mediator selection within 15 days
11-03-2026
LaFayette Acquisition Corp., a SPAC, filed its 10-K annual report outlining its focus on acquisition targets with enterprise values of $500M to $1.5B, fundamentally sound financials, and positive cash flows. The filing highlights risks such as potential insider loans up to $1.5M convertible into units at $10.00 per unit, conflicts of interest, and impacts from debt or share issuances. Financial statements cover the year ended December 31, 2025, and the period from inception (June 7, 2024) through December 31, 2024, but specific performance metrics are not detailed in the provided content.
- ·Company inception date: June 7, 2024
- ·Financial statements include Balance Sheets as of December 31, 2025 and 2024; Statements of Operations, Changes in Shareholders’ Deficit, and Cash Flows for year ended December 31, 2025 and period from inception through December 31, 2024
- ·Potential non-interest bearing loans from initial shareholders or affiliates for transaction costs, with no written agreements yet
11-03-2026
Advasa Holdings, Inc., a Delaware-incorporated emerging growth company and holding company with operations in the US and Japan (SIC 7372), filed Pre-Effective Amendment No. 3 to its Form S-1 (Reg. No. 333-292013) on March 10, 2026, registering 485,469,380 shares of common stock (par value $0.00001) for resale by existing Registered Stockholders via a direct listing on Nasdaq Global Market under symbol 'ADBT', with no proceeds to the company and costs borne by it for compliance. The direct listing lacks traditional underwriting, potentially leading to higher volatility and no established public market, while a 10-for-1 forward stock split was effective December 4, 2025; trading is expected on or about [_____], 2026, subject to Nasdaq approval, which if denied would terminate the process. Investing involves a high degree of risk as highlighted in the prospectus.
- ·Registrant classified as non-accelerated filer, smaller reporting company, and emerging growth company.
- ·Principal executive offices: 1-2-7 Moto-Akasake, Minato-ku, Tokyo, 107-0051 Japan.
- ·Agent for service: Corporate Creations Network Inc., 1521 Concord Pike, Suite 201, Wilmington, Delaware 19803.
- ·Shares eligible under Rule 415 for delayed or continuous offering.
11-03-2026
Cantor Equity Partners V, Inc. appointed Charlotte Blechman as a Class I director, Audit Committee member, and Compensation Committee member, effective March 10, 2026. Ms. Blechman brings extensive experience in marketing, branding, and public relations, including roles as Senior Managing Director at ACTUM since November 2025 and prior positions at Tom Ford Retail LLC and Barneys New York, as well as directorships at multiple SPACs. In connection with her appointment, the Board approved $50,000 annual compensation, paid quarterly.
- ·Ms. Blechman served as Chief Marketing Officer of Tom Ford Retail LLC from January 2017 to June 2023.
- ·No family relationships between Ms. Blechman and any director or executive officer.
- ·Company is an emerging growth company; Class A ordinary shares trade as CEPV on Nasdaq.
11-03-2026
C3.ai reported Q3 FY2026 total revenue of $53.3M, down 46% YoY from $98.8M, driven by subscription revenue declining 44% to $48.2M and professional services dropping 61% to $5.1M. While sales and marketing expenses rose 10% YoY to $67.2M and R&D remained nearly flat at $58.8M, gross profit plummeted 84% to $9.2M, resulting in a wider net loss of $133.4M (vs. $80.2M prior year). For the nine months FY2026, revenue fell 29% YoY to $198.7M, with net loss expanding 70% to $354.8M from $209.0M.
- ·Accounts receivable net: $123.6M as of Jan 31, 2026 (down from $137.2M at Apr 30, 2025)
- ·Deferred revenue current: $37.5M as of Jan 31, 2026 (up slightly from $36.6M)
- ·Net loss per share Q3 FY2026: $(0.94) (vs. $(0.62) prior year)
11-03-2026
TLGY Acquisition Corp held an extraordinary general meeting of shareholders on March 10, 2026, approving all proposals related to its Business Combination with StablecoinX Assets Inc., including the Business Combination Proposal, SPAC Merger Proposal, and eight advisory Organizational Documents Proposals, each passing with 5,759,409 votes in favor and only 2,000 against out of 5,761,409 shares present (97% quorum). However, shareholders redeemed 388,406 Class A Ordinary Shares, representing approximately 6.7% of the 5,834,587 Class A shares outstanding as of the February 4, 2026 record date.
- ·Business Combination Agreement originally dated July 21, 2025, and amended January 21, 2026.
- ·Registration Statement on Form S-4 declared effective February 17, 2026.
- ·Ordinary Shares par value $0.0001 per share.
11-03-2026
TLGY Acquisition Corp held an extraordinary general meeting on March 10, 2026, where shareholders overwhelmingly approved the Business Combination with StablecoinX Assets Inc., including the SPAC Merger and advisory organizational document proposals, with 5,759,409 votes in favor and only 2,000 against across all proposals, representing nearly 100% approval among votes cast. Approximately 97% of entitled shares were present, constituting a quorum. However, shareholders redeemed 388,406 Class A Ordinary Shares from the trust account.
- ·Business Combination Agreement originally dated July 21, 2025, and amended January 21, 2026
- ·Registration Statement on Form S-4 declared effective February 17, 2026
11-03-2026
On March 6, 2026, CERO Therapeutics Holdings, Inc. issued and sold a convertible promissory note to Keystone Capital Partners, LLC for a purchase price of $750,000, with a principal face value of $937,500 and capacity to borrow up to an aggregate of $1M. The note carries 10% annual interest, matures on August 6, 2027, and is convertible into common stock at the lesser of $0.05 or 80% of the average of the five lowest intraday trading prices over the prior 20 trading days, subject to a 4.99% beneficial ownership limit. The transaction relies on exemptions under Section 4(a)(2) and Rule 506(b) of the Securities Act, with the company required to file a resale registration statement.
- ·Note form incorporated by reference from February 13, 2026 Form 8-K (Exhibit 4.1)
- ·Issued in reliance on Section 4(a)(2) of the Securities Act and Rule 506(b)
- ·Company to file Form S-1 or S-3 registration statement for resale of conversion shares
11-03-2026
AeroVironment's Q3 revenue surged 143% YoY to $408M, propelled by acquisitions introducing Space and Directed Energy ($53M) and Cyber and Mission Services ($76M) segments, with Precision Strike up 87% to $158M; nine-month revenue rose 145% to $1.3B. However, a $151M goodwill impairment, elevated SG&A (up 127% to $99M), and higher debt interest contributed to a Q3 net loss of $157M (vs $1.8M loss) and nine-month net loss of $241M (vs $27M profit), with Uncrewed Aircraft Systems revenue nearly flat nine-month YoY at $243M. Total assets expanded to $5.45B from $1.12B as of April 30, 2025, reflecting acquisitions funded by $2.6B stock issuance and $728M long-term debt.
- ·Cash used in operating activities nine months: $174M (vs $1M prior)
- ·Business acquisitions net of cash: $845M
- ·Proceeds from shares issued: $969M
- ·Proceeds from convertible debt: $727M
- ·Allowance for credit losses: $2.2M (up from $0.2M)
11-03-2026
Boxabl Inc. appointed Shanmugam 'Shan' Palaniappan as Chief Technology Officer on March 10, 2026, to bolster software, automation, and AI capabilities as it advances toward a merger with FG Merger II Corp., per the agreement signed August 4, 2025. The move supports Boxabl's transition to an industrial-scale housing manufacturer, with no financial metrics disclosed. Forward-looking statements highlight potential benefits but note risks including merger approval delays and redemptions.
- ·Boxabl founded in 2017.
- ·Merger Agreement dated August 4, 2025, involves two-step merger with FG Merger Sub II Inc.; FGMC to become Surviving Pubco named BOXABL Inc.
- ·FGMC IPO prospectus filed January 29, 2025; Boxabl 10-K filed April 14, 2025.
11-03-2026
Metropolitan Life Insurance Company reported total revenues of $43.3B for the year ended December 31, 2025, up 3.3% YoY from $41.9B, driven by 10.9% growth in premiums to $30.6B. However, net income attributable to the company fell 55.2% YoY to $1.6B from $3.5B, due to higher policyholder benefits ($32.6B, +11.4%), larger net investment losses ($992M) and derivative losses ($1.1B), and elevated total expenses ($41.5B, +10.2%). Cash increased by $1.1B, more than double the prior year's $476M.
- ·Sensitivity analysis shows a 1% mortality increase impacts FPBs pre-tax net income by +$93M and OCI by -$13M.
- ·Net change in interest rate risk exposure improved to -$2.9B from prior year's -$2.5B under 100 bps rate increase scenario.
- ·Dividends paid to MetLife, Inc. decreased to $2.3B from $3.5B.
11-03-2026
Sparkle Gold Rock Limited (formerly Sree Jayalakshmi Autospin Limited) has clarified that a penalty order issued by the Office of the Principal Commissioner of Customs, Chennai-III on December 15, 2025, applies solely to Sree Jayalakshmi Autospin Private Limited and imposes no liability on the company. The current board of directors states it was not involved in the alleged transactions, which lack substantive proof and pertain to a prior period. The company has filed objections and is pursuing legal recourse, with no financial impact disclosed.
- ·CIN: L32111RJ1991PLC106196
- ·Scrip Code: 530037
- ·Previous BSE announcement date: January 21, 2026
- ·Director DIN: 09831479
11-03-2026
Starz Entertainment Corp. (NASDAQ: STRZ) announced its Board unanimously adopted a limited-duration shareholder protection rights agreement (Rights Plan) effective March 10, 2026, set to expire March 10, 2027 unless extended. The plan issues one right per common share with a record date of March 20, 2026, becoming exercisable if any person or group acquires 17.5% or more beneficial ownership, entitling other shareholders to purchase shares at a 50% discount. It aims to protect long-term shareholder value and prevent control without fair compensation, applying equally to all shareholders without intent to deter fair offers.
- ·Rights agent: Computershare Investor Services Inc.
- ·Agreement dated March 10, 2026; full text in Form 8-K on EDGAR (www.sec.gov) and SEDAR+ (www.sedarplus.ca).
- ·Existing owners above 17.5% exempt from triggering but cannot acquire additional shares.
11-03-2026
Blue Water Acquisition Corp. IV (BWIV), a SPAC, filed an S-1/A registration statement on March 11, 2026, for its initial public offering of units at an offering price of $10.00 per unit. The filing includes extensive pro forma tables detailing net tangible book value per share across scenarios with and without overallotment option exercise and public shareholder redemptions at 0%, 25%, 50%, 75%, or 100% of maximum as of December 31, 2025. Founder shares were issued on August 1, 2025, and private placement units are referenced for the sponsor.
- ·Pro forma net tangible book value calculations exclude offering costs accrued or paid in advance, deferred underwriting commissions, overallotment liability, and redemptions
- ·Scenarios assume ordinary shares outstanding prior to offering and potential founder share forfeitures if overallotment not exercised
11-03-2026
Johnson & Johnson's 2026 Proxy Statement for the virtual Annual Meeting on April 23, 2026, seeks shareholder approval to elect 12 directors (including new members Daniel Pinto and John Morikis), advisory vote on NEO compensation, ratification of PricewaterhouseCoopers LLP as auditors, and recommends against a shareholder proposal for an independent board chair. The Lead Independent Director highlights exceptional 2025 financial performance driven by innovation in Oncology, Immunology, Neuroscience, Cardiovascular, Surgery, and Vision, alongside plans to separate the Orthopaedics business to focus on higher-growth areas. Credo initiatives report strong social impacts, including >2.8B Vermox doses delivered since 2006 and a 26% reduction in Scope 1 & 2 GHG emissions from 2021-2024, with high employee satisfaction ratings of 85-89%.
- ·Record date: February 24, 2026
- ·Annual Meeting: April 23, 2026, 10:00 a.m. ET, virtual at www.virtualshareholdermeeting.com/JNJ2026
11-03-2026
11-03-2026
Pono Capital Four, Inc., a Cayman Islands blank check company (SPAC), filed Amendment No. 2 to its S-1 registration statement on March 11, 2026, for an initial public offering of 15,000,000 units at $10.00 each, targeting gross proceeds of $150M, with underwriters' over-allotment option for 2,250,000 additional units. Sponsor Mehana Ventures LLC holds 7,392,857 Class B founder shares (purchased for $25,000 or ~$0.003/share, up to 964,286 forfeitable), maintaining ~30% post-IPO ownership on an as-converted basis, which will cause immediate and substantial dilution to public shareholders due to the nominal founder share price and anti-dilution protections. Private placements include 190,000 units ($1.9M) committed by sponsor and Private Placement Investor, plus potential 110,000 units ($1.1M) from non-managing sponsor investors.
- ·SEC file number: 333-293120
- ·Filer CIK: 0002108164
- ·EIN: 98-1907673
- ·Principal executive offices: Suite 210, 2nd Floor Windward III, Regatta Office Park, PO Box 500, Grand Cayman, KY-1106
- ·Business address: 643 Ilalo Street, #102, Honolulu, HI 96813
- ·IPO commencement: As soon as practicable after effective date
- ·Redemption price: Trust account net asset value per public share (net of taxes, excluding excise taxes)
- ·Non-managing sponsor investors not affiliated with management or sponsor; no obligation to vote for business combination
11-03-2026
Oracle reported strong Q3 revenue growth of 22% YoY to $17.2B, driven by Cloud revenues surging 44% to $8.9B, while total nine-month revenues rose 16% to $48.2B. However, Software revenues were nearly flat down 0.2% YoY at $17.7B for nine months, Hardware grew modestly 4% to $2.2B, and the company significantly increased capital expenditures to $39.2B alongside higher debt to $134.6B non-current notes payable. Net income for nine months jumped 42% to $12.8B, supported by operating cash flow up 18% to $17.4B.
- ·Diluted EPS nine months $4.38 vs $3.15 (+39%)
- ·Cash dividends declared per common share nine months $1.50 vs $1.20
- ·Unpaid capital expenditures $4.5B as of Feb 28, 2026
- ·Trade receivables net $10.7B vs $8.6B
- ·Restructuring expenses nine months $961M vs $220M
11-03-2026
Pelican Acquisition Corporation clarified that, as a Cayman Islands exempted company, it is not a 'covered corporation' under Section 4501 of the Internal Revenue Code, so the 1% excise tax on stock repurchases is not expected to apply to redemptions of ordinary shares in connection with the shareholder vote on its proposed Business Combination with Greenland Exploration Limited and March GL Company. This means public shareholders electing to redeem should receive full cash amounts without tax reduction. However, this is based on current guidance, and future U.S. Treasury or IRS regulations could alter this, potentially retroactively.
- ·Company address: 1185 Avenue of the Americas, Suite 349, New York, NY 10036.
- ·Securities listed on Nasdaq: Units (PELIU), Ordinary shares (PELI, $0.0001 par value), Rights (PELIR).
- ·Emerging growth company status confirmed.
- ·Press Release dated March 11, 2026 attached as Exhibit 99.1.
11-03-2026
Cintas Corporation announced a definitive agreement to acquire UniFirst Corporation for $310 per share in cash and stock, representing a $5.5B enterprise value at 8.0x run-rate trailing 12-month EBITDA, with expected $375M in operating cost synergies within four years and accretion to EPS by the end of the second full year post-closing. The deal enhances service capabilities for 1.5M customers across North America and is expected to close in H2 2026, subject to approvals. Cintas reported preliminary Q3 FY2026 revenue of $2.84B, up 8.9% YoY from $2.61B (organic growth 8.2%), with full results on March 25, 2026.
- ·Transaction multiple of 8.0x run-rate trailing 12 months EBITDA including $375M synergies.
- ·Net leverage ratio at close expected to be 1.5x debt to EBITDA.
- ·Croatti family entities control ~2/3 of UniFirst voting power and entered voting support agreement.
- ·UniFirst Q2 FY2026 results on April 1, 2026; no further conf calls or guidance due to transaction.
11-03-2026
Fenoplast Limited has set Monday, March 23, 2026, as the record date for ascertaining shareholders eligible for selective reduction and extinguishment of equity share capital under the NCLT Hyderabad Bench-approved resolution plan dated January 22, 2025. The entire 100% promoter group shareholding will be extinguished, with public shareholders facing cancellation of 19 out of every 20 shares (95% reduction), resulting in one new ₹10 equity share for every 20 held. This insolvency resolution action significantly dilutes existing shareholders with no offsetting positive financial metrics reported.
- ·Scrip Code: 526689
- ·NCLT Hyderabad Bench Order dated 22.01.2025
- ·Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015 and IBC, 2016
11-03-2026
Smurfit Westrock's 2026 Proxy Statement reports strong 2025 financial performance with $31.2B net sales, $4.9B Adjusted EBITDA (15.8% margin), and $1.5B Adjusted Free Cash Flow, exceeding the committed $400M synergy goal despite challenging market conditions in some countries. The Company increased its quarterly dividend by 5% to $0.4523 per share and launched a Medium-Term Plan guiding operations through 2030. At the May 1, 2026 AGM, shareholders will vote on electing 12 directors (with Terrell Crews and Lourdes Melgar stepping down), advisory approval of NEO compensation, and ratification of KPMG as auditor.
- ·AGM location: Minerva Suite, RDS, Merrion Road, Ballsbridge, Dublin 4, D04 AK83, Ireland at 10:00 a.m. Dublin Time (registration 9:30 a.m.)
- ·Record date: March 3, 2026
- ·Paper and board manufacturing capacity: approximately 23 million tons per annum
11-03-2026
Pelican Acquisition Corporation issued a clarification stating it does not expect the 1% excise tax under Section 4501 to apply to redemptions of its ordinary shares in connection with the shareholder vote on its proposed Business Combination with Greenland Exploration Limited, March GL Company, and other parties, as the Company is a Cayman Islands exempted company and not a 'covered corporation.' Public shareholders electing to redeem should receive full cash without excise tax reduction. This is based on current guidance, though future Treasury or IRS regulations could alter applicability, potentially retroactively.
- ·Filing includes Exhibit 99.1: Press Release dated March 11, 2026.
- ·Securities traded on Nasdaq: Units (PELIU), Ordinary shares (PELI), Rights (PELIR).
11-03-2026
AGI Greenpac Limited has intimated under Regulation 30(6) of SEBI (LODR) Regulations, 2015, about a scheduled one-on-one virtual meeting with Ageless Capital and Finance on March 12, 2026. The schedule is subject to change due to exigencies. No financial or performance data was disclosed in this filing.
- ·BSE Scrip Code: 500187; NSE Symbol: AGI
- ·CIN: L51433WB1960PLC024539
- ·Corporate Office: 301-302, Park Centra, Sector-30, Gurugram-122001, Haryana, India
- ·Registered Office: 2, Red Cross Place, Kolkata-700001, West Bengal, India
- ·AGI glaspac Office: Glass Factory Road, Off Motinagar, Borabanda, Hyderabad-500018, India
- ·AGI Plastek Premises: Glass Factory Road, Off Motinagar, Borabanda, Hyderabad-500018, India
- ·AGI CloZures Office: Sy.No.208 to 218, Sitarampur, Isnapur, Patancheru, Telangana-502307, India
11-03-2026
Cintas Corporation announced a definitive merger agreement on March 10, 2026, to acquire UniFirst Corporation through a two-step merger process, with UniFirst shareholders receiving $155 in cash and 0.7720 shares of Cintas common stock per share of UniFirst common stock. The transaction is subject to UniFirst shareholder approval (requiring a two-thirds vote), regulatory clearances including HSR Act waiting period expiration, and other customary conditions, with an outside termination date of January 10, 2027 (potentially extendable). Termination fees are set at $213.3M payable by UniFirst to Cintas and $350M payable by Cintas to UniFirst under specified circumstances.
- ·UniFirst equity awards (RSUs, SARs, PSUs) to be treated as terminating (cashed out) or continuing (converted to Cintas awards) based on predefined categories.
- ·Deal closing subject to NASDAQ listing approval for Cintas shares, SEC registration statement effectiveness, no material adverse effect on either company, and absence of prohibiting injunctions.
11-03-2026
Ryder System Inc's 2026 Proxy Statement for the May 1, 2026 annual meeting highlights robust 2025 financial performance, including diluted EPS of $11.99 (up 8.4% from $11.06), comparable EPS of $12.92 (up 7.7% from $12.00), total revenue of $12.7B, net earnings of $499M (up 2.0% from $489M), and comparable EBITDA of $2.9B (up 3.6% from $2.8B), achieved amid a prolonged freight market downturn. The meeting proposes electing 11 directors (board recommends for all), ratifying PricewaterhouseCoopers LLP as auditors (for), advisory approval of NEO compensation (for), and an advisory shareholder proposal for an independent board chair (against). Three-year TSR reached 146%, outperforming S&P 400 MidCap (+42%) and Dow Jones Transportation average (+36%).
- ·Record date for voting: March 2, 2026
- ·Annual meeting location: The Breakers Palm Beach, One South County Road, Palm Beach, Florida 33480
- ·Proxy materials first sent: on or about March 11, 2026
11-03-2026
Kirloskar Industries Limited was issued a notice by NSE on 13 February 2026 for a one-day delay in compliance with Regulation 31(1) of SEBI Listing Regulations for the quarter ended 31 December 2025, leading to a fine of ₹2,000 plus 18% GST (total ₹2,360). The company submitted a waiver application on 20 February 2026, and the Board of Directors took note of the notice and actions in its meeting on 11 March 2026. No payment has been confirmed, and potential further actions like promoter shareholding freeze loom if unresolved.
- ·Notice reference: NSE/LIST-SOP/FINES/0155 dated 13 February 2026
- ·Non-compliance specific to quarter ended 31 December 2025
- ·Waiver application submitted via NEAPS on 20 February 2026
- ·Board required to be informed, comments disseminated as 'Board comments on fine levied by the Exchange'
11-03-2026
Athena Technology Acquisition Corp. II, a SPAC, reported a reduced net loss of $1.3M for the year ended December 31, 2025, compared to $2.6M in 2024, driven by a 45% YoY decline in operating expenses to $1.9M and a $888K reversal of excise tax liability. However, investments held in the Trust Account plummeted 92% YoY to $298K amid heavy redemptions that reduced redeemable Class A shares from 310,156 to 24,887, causing total assets to drop 70% to $1.4M while liabilities remained elevated at $18.0M. Cash and equivalents rose to $348K from $142K, bolstered by $500K in related-party promissory notes and $400K from Polar subscription.
- ·Sponsor issued promissory notes totaling $500K ($300K initial + $200K on Dec 6, 2024), repayable upon business combination closing; in exchange, up to 500K Class A shares to be transferred/issued to Polar.
- ·Deferred underwriting fee payable remains $8.96M.
- ·Stockholders’ deficit improved to $(17.0M) from $(18.9M), aided by $2.6M reversal of excise tax liability.
- ·Business address: 442 5th Avenue, New York, NY 10018.
11-03-2026
Sonida Senior Living, Inc. completed its $1.8B strategic merger with CNL Healthcare Properties, Inc., acquiring 100% of CHP for $7.22 per share ($4.58 stock + $2.32 cash), creating a $3.3B pure-play senior housing owner-operator with 153 owned communities (~14,700 units), making it the eighth largest U.S. senior living owner. The deal delivers estimated 62% Normalized FFO per share accretion on a run-rate basis, with Sonida's existing shareholders owning 50% of the combined entity, and strengthens the balance sheet via $930M permanent debt financing (expandable to $1.25B). No quantitative declines reported, though forward-looking risks include integration challenges and debt refinancing.
- ·Merger agreement dated November 4, 2025; Sonida stockholder meeting February 26, 2026 (91% quorum, 18,277,189 shares present); exchange ratio 0.1318x based on $4.58 stock value and VWAP with 15%-30% collar ($22.73-$34.76 reference).
- ·CHP external advisor resources available for 90 days post-closing; some employees joining permanently.
- ·Sam Levinson to join Board effective May 1, 2026.
- ·Portfolio spans South, Southeast, Midwest, Mountain West, Pacific Northwest, Mid-Atlantic; 54 communities managed by third-parties, 15 leased, 4 JV consolidated, 4 JV unconsolidated.
11-03-2026
Kamada Ltd provided FY2026 guidance expecting total revenues of $200M-$205M (13% YoY growth at midpoint) and adjusted EBITDA of $50M-$53M (23% YoY growth at midpoint), driven by Proprietary Products like KEDRAB, GLASSIA, and CYTOGAM, plus Takeda royalties of $10M-$20M annually. The company plans biosimilar launches in Israel (2 in 2026, 1-3/year thereafter) targeting $15M-$20M revenues in 4-5 years, and U.S. plasma center ramp-ups in Houston and San Antonio expected to each generate $8M-$10M annual revenues once operational. No declines or flat performance noted in guidance.
- ·San Antonio plasma site expected to receive FDA approval in H1 2026
- ·Intention to apply for EMA approval for Houston and San Antonio plasma centers for European sales
- ·Biosimilar launches in Israel subject to EMA and IMOH approvals
11-03-2026
Valmont Industries' 2026 Proxy Statement details robust corporate governance, including a board where all directors except CEO Mr. Applbaum are independent, strict insider trading policies, and no Shareholder Rights Plan; director nominations emphasize diversity and skills, with recent additions like Paul T. Maass in 2026. Compensation targets market medians via FW Cook surveys of ~500 companies and a 16-company peer group, supported by strong say-on-pay votes (96.3% in 2025). However, company revenues remained flat at ~$4.1B from 2024 to 2025.
- ·Shareholder director nominations must be submitted to Corporate Secretary at least 120 days before annual meeting.
- ·Equity awards granted in February (PSUs) and December (options/RSUs); no timing to material nonpublic info.
- ·Peer group revised in Oct 2025: removed Barnes Group (acquired), Comfort Systems, Hubbell, Xylem; added Atkore, AZZ, Timken.
- ·Board additions: Joan Robinson-Berry and Ritu Favre (2020), Deborah Caplan (2024), Paul T. Maass (2026).
11-03-2026
Campbell's net sales declined 4.5% YoY to $2,564M for the three months ended February 1, 2026, with net earnings falling 16.2% to $145M ($0.49 per share basic). Over the six months ended February 1, 2026, net sales decreased 4.0% YoY to $5,241M and net earnings dropped 13.3% to $339M ($1.14 per share). However, net cash provided by operating activities was flat at $740M YoY, cash and equivalents surged to $561M from $132M at August 3, 2025, and shareholders' equity rose to $4,007M.
- ·Cost of products sold declined to $1,847M (three months) from $1,866M YoY (-1.0%)
- ·Interest expense decreased to $82M (three months) from $88M YoY
- ·Short-term borrowings down to $428M from $762M at Aug 3, 2025
- ·Dividends paid $237M six months ended Feb 1, 2026 (up from $227M YoY)
- ·Net cash used in investing activities increased to $234M from $175M YoY six months
11-03-2026
Mainz Biomed N.V. (NASDAQ: MYNZ) appointed Robert P. Liscouski as Chairman of its Board of Directors, effective pending approval at an extraordinary general meeting in April 2026, while planning to change its name to Quantum Cyber and Nasdaq ticker to QUCY starting March 12, 2026. The company continues progress on its pancreatic cancer screening business in the U.S., evaluating sale of colorectal cancer screening assets, and winding down its German subsidiary. Mr. Liscouski brings over 35 years of experience in cybersecurity, AI, quantum computing, and government infrastructure protection.
- ·Name and ticker changes (to Quantum Cyber / QUCY) effective for business and trading on March 12, 2026; permanent election and name change at EGM in April 2026
- ·Prior SEC filings referenced: Form 20-F filed March 31, 2025; Form 6-K filed September 26, 2025
11-03-2026
Sagimet Biosciences Inc. reported a net loss of $51.0M for the year ended December 31, 2025, up 12% YoY from $45.6M in 2024, driven by a 4% increase in total operating expenses to $56.9M despite flat R&D expenses at 2% growth. While clinical development costs declined 12% YoY, manufacturing expenses rose 34% and G&A increased 11%, with cash used in operations worsening to $45.7M from $42.4M, leading to a net cash decrease of $40.8M. Other income fell 34% to $5.9M, and the company highlighted ongoing risks including cash sufficiency and lack of marketing capabilities.
- ·External R&D subtotal remained nearly flat at -1% YoY ($34.3M vs $34.6M).
- ·Investing activities provided $4.6M cash inflow in 2025 vs $61.7M outflow in 2024.
- ·Financing activities generated only $0.3M in 2025 vs $104.8M in 2024.
11-03-2026
Gujarat State Petronet Limited (GSPL) received fines of ₹53,100 each (basic fine ₹45,000 + 18% GST ₹8,100) from BSE and NSE for non-compliance with Regulation 17(1) of SEBI LODR on board composition during the quarter ended December 31, 2025, attributed to 9 days of violation at ₹5,000 per day. The Board met on March 11, 2026, took the notices on record, and decided to file waiver applications with both exchanges. No fines have been paid yet; waiver requires processing fee of ₹11,800 (₹10,000 + 18% GST) to the designated exchange.
- ·Non-compliance pertains to board composition under Regulation 17(1) SEBI LODR for quarter ended Dec 31, 2025.
- ·Fines notices dated February 27, 2026 (both exchanges); BSE follow-up email March 4, 2026.
- ·Waiver applications to be submitted via BSE Listing Centre and NSE NEAPS portals.
11-03-2026
Narayana Hrudayalaya Limited issued a corrigendum on March 11, 2026, to its EGM notice dated February 26, 2026, correcting a typographical error in the e-voting cut-off date from March 27, 2026, to March 26, 2026, for the Extraordinary General Meeting scheduled on April 2, 2026. The EGM is to approve the Scheme of Arrangement (demerger) between NH Integrated Care Private Limited (Demerged Company) and Narayana Hrudayalaya Limited (Resulting Company), as directed by the National Company Law Tribunal, Bengaluru Bench. No other changes were made to the original notice.
- ·EGM to be held on Thursday, April 02, 2026 at 10:00 A.M. (IST) through VC/OAVM.
- ·Scrip codes: BSE - 539551 (EQ), 975516, 976418; NSE - NH.
- ·Documents available at https://www.narayanahealth.org/stakeholder-relations/demerger-2026.
11-03-2026
GIC Private Limited, acting on behalf of Government of Singapore (GOS) and Monetary Authority of Singapore (MAS), disclosed a sale of 485,902 equity shares (0.126%) of InterGlobe Aviation Limited on March 9, 2026, via open market, reducing their combined holding from 12,022,212 shares (3.110%) to 11,536,310 shares (2.984%). GOS's stake fell from 2.512% to 2.405%, while MAS's declined from 0.598% to 0.579%. This follows prior sales since December 2024, when holdings were at 5.00%.
- ·Disclosure triggered under Regulation 29(2) of SEBI (SAST) Regulations due to aggregate sales since Dec 2024 reducing stake below thresholds.
- ·Mode of transaction: Open Market Sale.
- ·Total paid-up equity share capital increased to 386,612,998 shares on Mar 5, 2026 post ESOP allotment.
11-03-2026
Lykis Limited's Committee of Independent Directors met on March 11, 2026, to review the open offer by Parshav Vatika LLP (Acquirer) with Persons Acting in Concert K8 Products LLP and Tidagela Ventures Private Limited to acquire up to 50,37,541 fully paid-up equity shares of ₹10 each, representing 26% of the total voting share capital, at ₹34.50 per share. The committee discussed, analyzed, and provided recommendations to shareholders under Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. No financial performance metrics or period comparisons were disclosed in the filing.
- ·Public Announcement dated December 18, 2025
- ·Detailed Public Statement dated December 25, 2025, published December 26, 2025
- ·Letter of Offer dated March 06, 2026
- ·Committee meeting commenced at 05:30 PM and concluded at 05:35 PM on March 11, 2026
- ·Scrip Code: 530689
11-03-2026
Cummins India Limited's Board, at its meeting on March 11, 2026, reviewed fines of ₹2,000 plus 18% GST (total ₹2,360 each) levied by BSE and NSE for non-compliance with Regulation 18(1) of SEBI LODR regarding audit committee constitution for the quarter ended December 31, 2025. The company described the lapse as inadvertent, confirmed payment of fines within timelines, reconstitution of the Audit and Compliance Committee effective November 11, 2025, and filing of a waiver application with outcome awaited. The Board reaffirmed commitment to regulatory compliance.
- ·Non-compliance pertains to constitution of audit committee under Regulation 18(1) for quarter ended December 31, 2025.
- ·SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
- ·Stock exchange emails dated February 27, 2026.
- ·Waiver application filed via NEAPS portal; processing fee of ₹10,000 + 18% GST applicable if fine > ₹5,000.
11-03-2026
Marsons Limited has received approval from NSE vide letter no. NSE/LIST/247 dated March 11, 2026, for listing of 172.1 million equity shares of Re. 1/- each fully paid up on the Main Board, effective March 13, 2026, under symbol MARSONS EQ (Series: EQ). The company has intimated BSE pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. No lock-in details apply to the shares with distinctive numbers 1 to 172100000.
- ·Distinctive numbers: 1 to 172100000
- ·Market lot: 1
- ·No lock-in details (NA)
- ·Listing effective: March 13, 2026
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)